| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO | EVP, North America Commercial
2 companies
O'Grady Brendan P. is a CEO at ASRT with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $3.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2019 | TEVA Teva Pharmaceutical Industries Ltd | EVP, North America Commercial | Sale+OE | 738 | $15.67 | $11,568.08 | -34.7% | |
| Mar 4, 2019 | TEVA Teva Pharmaceutical Industries Ltd | EVP, North America Commercial | Sale+OE | 1,166 | $16.88 | $19,685.93 | -45.6% | |
| Sep 18, 2018 | TEVA Teva Pharmaceutical Industries Ltd | EVP, North America Commercial | Sale+OE | 1,241 | $23.71 | $29,420.39 | -47.2% | |
| Mar 19, 2018 | TEVA Teva Pharmaceutical Industries Ltd | EVP, North America Commercial | Sale+OE | 1,179 | $17.88 | $21,078.16 | -45.9% | |
| Mar 12, 2018 | TEVA Teva Pharmaceutical Industries Ltd | EVP, North America Commercial | Sale+OE | 738 | $19.49 | $14,382.88 | -34.7% | |
| Mar 5, 2018 | TEVA Teva Pharmaceutical Industries Ltd | EVP, North America Commercial | Sale+OE | 705 | $19.38 | $13,662.90 | -33.7% |